13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001687509
Total reported value
$10.9B
$10.9B
66 檔
25.6%
At the close of Q2 2025, Rubric Capital Management LP disclosed equity holdings valued at approximately $10.9B, spread across 66 reported holdings.
Rubric Capital Management LP executed strategic sector rebalancing during Q2 2025, establishing 10 new positions while fully exiting 9 holdings and trimming 21 positions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | TLN | Talen Energy CORP | Stock-Utilities | 19.79% | +0.52% | -26.43% | |
| 2 | TEVA | Teva Pharmaceutical-sp Adr | Stock-Healthcare | 6.58% | -0.03% | +1.76% | |
| 3 | FTAI | FTAI Aviation Ltd. | Stock-Industrials | 5.90% | +0.76% | +28.32% | |
| 4 | GLNG | Golar LNG Limited | Stock-Energy | 5.71% | -1.06% | +2.27% | |
| 5 | VST | Vistra CORP | Stock-Utilities | 4.17% | +0.22% | +50.62% | |
| 6 | ROIV | Roivant Sciences Ltd. | Stock-Healthcare | 3.47% | +0.48% | +14.65% | |
| 7 | FLR | Fluor CORP | Stock-Industrials | 3.10% | +2.41% | NEW | |
| 8 | BGC | Bgc Group Inc-a | Stock-Financials | 2.63% | -0.08% | -1.28% | |
| 9 | TAC | Transalta CORP | Stock-Other | 2.60% | +0.10% | +32.90% | |
| 10 | XBI | Ss Spdr S&p Biotech ETF | ETF-Tech | 2.51% | — | — | |
| 11 | ARQT | Arcutis Biotherapeutics Inc | Stock-Other | 2.28% | -0.07% | -1.98% | |
| 12 | MCY | Mercury General CORP | Stock-Other | 2.09% | -0.50% | +12.77% | |
| 13 | TSLA | Tesla Inc | Stock-Consumer Disc | 2.06% | — | — | |
| 14 | QDEL | Quidelortho CORP | Stock-Other | 2.02% | -0.05% | -24.47% | |
| 15 | ALIT | Alight Inc - Class A | Stock-Other | 1.68% | — | +10.76% | |
| 16 | KNSA | Kiniksa Pharmaceuticals International, plc | Stock-Other | 1.63% | +0.44% | +15.56% | |
| 17 | VTRS | Viatris Inc | Stock-Healthcare | 1.62% | +0.19% | — | |
| 18 | SDGR | Schrodinger Inc | Stock-Other | 1.52% | +0.23% | +4.17% | |
| 19 | RNW | ReNew Energy Global Plc | Stock-Other | 1.51% | +0.10% | -0.62% | |
| 20 | HIMS | Hims & Hers Health Inc | Stock-Healthcare | 1.51% | — | — | |
| 21 | AMRX | Amneal Pharmaceuticals Inc | Stock-Other | 1.43% | +0.16% | +9.08% | |
| 22 | COLL | Collegium Pharmaceutical Inc | Stock-Other | 1.41% | -0.03% | +5.26% | |
| 23 | IART | Integra Lifesciences Holding | Stock-Other | 1.36% | +0.51% | +58.36% | |
| 24 | SSYS | Stratasys Ltd. | Stock-Other | 1.35% | -0.03% | +18.28% | |
| 25 | NFE | New Fortress Energy Inc | Stock-Other | 1.22% | — | +0.25% | |
| 26 | ADPT | Adaptive Biotechnologies | Stock-Other | 1.10% | — | -52.30% | |
| 27 | INDV | Indivior Pharmaceuticals, Inc. | Stock-Other | 1.03% | — | +31.65% | |
| 28 | OPK | Opko Health Inc | Stock-Other | 0.95% | +0.08% | -1.88% | |
| 29 | ADEA | Adeia Inc | Stock-Other | 0.92% | -0.45% | -1.17% | |
| 30 | ZYME | Zymeworks Inc | Stock-Other | 0.89% | -0.18% | +8.58% | |
| 31 | LBTYA | Liberty Global Ltd. | Stock-Other | 0.86% | -0.28% | -5.17% | |
| 32 | DK | Delek US Holdings Inc | Stock-Other | 0.86% | -0.03% | — | |
| 33 | HRTX | Heron Therapeutics Inc | Stock-Other | 0.84% | -0.13% | — | |
| 34 | 07WA | Mr Cooper Group Inc | Stock-Other | 0.76% | — | -63.33% | |
| 35 | PCG | P G & E CORP | Stock-Utilities | 0.76% | — | — | |
| 36 | TRVI | Trevi Therapeutics Inc | Stock-Other | 0.70% | -0.04% | +87.99% | |
| 37 | CNNE | Cannae Holdings Inc | Stock-Other | 0.66% | — | +41.31% | |
| 38 | OFIX | Orthofix Medical Inc | Stock-Other | 0.63% | -0.14% | +0.72% | |
| 39 | MREO | Mereo Biopharma Group Pl-adr | Stock-Other | 0.63% | -0.01% | — | |
| 40 | PRLB | Proto Labs Inc | Stock-Other | 0.63% | -0.21% | +791.90% | |
| 41 | ECVT | Ecovyst Inc | Stock-Other | 0.59% | -0.30% | — | |
| 42 | LBTYA | Liberty Global Ltd. | Stock-Other | 0.51% | -0.22% | -0.11% | |
| 43 | XPER | Xperi Inc | Stock-Other | 0.50% | +0.06% | — | |
| 44 | GEO | Geo Group Inc/the | Stock-Other | 0.45% | +0.45% | +84.56% | |
| 45 | MATV | Mativ Holdings Inc | Stock-Other | 0.41% | -0.09% | -0.44% | |
| 46 | CMPR | Cimpress plc | Stock-Other | 0.40% | +0.37% | — | |
| 47 | IAS | Integral Ad Science Holding | Stock-Other | 0.37% | — | -6.16% | |
| 48 | MGTX | MeiraGTx Holdings plc | Stock-Other | 0.37% | +0.49% | +109.78% | |
| 49 | SPRY | Ars Pharmaceuticals Inc | Stock-Other | 0.34% | -0.05% | +25.83% | |
| 50 | SUPN | Supernus Pharmaceuticals Inc | Stock-Healthcare | 0.33% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | FLR | Fluor CORP | +3.1% | NEW | New buy |
| 2 | XBI | Ss Spdr S&p Biotech ETF | +2.5% | NEW | New buy |
| 3 | VST | Vistra CORP | +2.2% | +50.62% | Add |
| 4 | TSLA | Tesla Inc | +2.1% | NEW | New buy |
| 5 | VTRS | Viatris Inc | +1.6% | NEW | New buy |
| 6 | HIMS | Hims & Hers Health Inc | +1.5% | NEW | New buy |
| 7 | PCG | P G & E CORP | +0.8% | NEW | New buy |
| 8 | FTAI | FTAI Aviation Ltd. | +0.6% | +28.32% | Add |
| 9 | TAC | Transalta CORP | +0.6% | +32.90% | Add |
| 10 | ECVT | Ecovyst Inc | +0.6% | NEW | New buy |
| 11 | PRLB | Proto Labs Inc | +0.6% | +791.90% | Add |
| 12 | INDV | Indivior Pharmaceuticals, Inc. | +0.4% | +31.65% | Add |
| 13 | CMPR | Cimpress plc | +0.4% | NEW | New buy |
| 14 | SUPN | Supernus Pharmaceuticals Inc | +0.3% | NEW | New buy |
| 15 | KNSA | Kiniksa Pharmaceuticals International, plc | +0.3% | +15.56% | Add |
| 16 | MCY | Mercury General CORP | +0.3% | +12.77% | Add |
| 17 | CEG | Constellation Energy | +0.3% | NEW | New buy |
| 18 | ROIV | Roivant Sciences Ltd. | +0.3% | +14.65% | Add |
| 19 | SSYS | Stratasys Ltd. | +0.2% | +18.28% | Add |
| 20 | TRVI | Trevi Therapeutics Inc | +0.2% | +87.99% | Add |
| 21 | ANIP | Ani Pharmaceuticals Inc | +0.2% | +354.68% | Add |
| 22 | CNNE | Cannae Holdings Inc | +0.2% | +41.31% | Add |
| 23 | MGTX | MeiraGTx Holdings plc | +0.2% | +109.78% | Add |
| 24 | DK | Delek US Holdings Inc | +0.1% | — | Unchanged |
| 25 | CXW | Corecivic Inc | +0.1% | +106.98% | Add |
| 26 | SPRY | Ars Pharmaceuticals Inc | +0.1% | +25.83% | Add |
| 27 | GEO | Geo Group Inc/the | +0.1% | +84.56% | Add |
| 28 | ZVRA | Zevra Therapeutics Inc | +0.1% | +60.82% | Add |
| 29 | SCPH | Scpharmaceuticals Inc | 0% | -3.62% | Trim |
| 30 | TSAT | Telesat CORP | 0% | -1.83% | Trim |
| 31 | MREO | Mereo Biopharma Group Pl-adr | 0% | — | Unchanged |
| 32 | TH | Target Hospitality CORP | — | +9.47% | Add |
| 33 | TXMD | Therapeuticsmd Inc | — | — | Unchanged |
| 34 | OPK 3.75 01-15-29Bond | Opko Health Inc | 0% | — | Unchanged |
| 35 | EDSA | Edesa Biotech Inc | 0% | — | Unchanged |
| 36 | MYPS | Playstudios Inc | 0% | -0.51% | Trim |
| 37 | RNW | ReNew Energy Global Plc | 0% | -0.62% | Trim |
| 38 | HOWL | Werewolf Therapeutics Inc | 0% | EXIT | Sold out |
| 39 | OVID | Ovid Therapeutics Inc | 0% | -91.00% | Trim |
| 40 | ZYME | Zymeworks Inc | 0% | +8.58% | Add |
| 41 | MATV | Mativ Holdings Inc | 0% | -0.44% | Trim |
| 42 | ABUS | Arbutus Biopharma CORP | 0% | -6.29% | Trim |
| 43 | SEG | Seaport Entertainment Group | -0.1% | -0.85% | Trim |
| 44 | CHRS | Coherus Oncology Inc | -0.1% | -83.50% | Trim |
| 45 | XPER | Xperi Inc | -0.1% | — | Unchanged |
| 46 | IAS | Integral Ad Science Holding | -0.1% | -6.16% | Trim |
| 47 | EMBC | Embecta CORP | -0.1% | -4.62% | Trim |
| 48 | ADEA | Adeia Inc | -0.1% | -1.17% | Trim |
| 49 | OABI | Omniab Inc | -0.1% | EXIT | Sold out |
| 50 | SDGR | Schrodinger Inc | -0.2% | +4.17% | Add |
According to official SEC Form 13F filings, Rubric Capital Management LP reported a total U.S. public equity portfolio value of $10.9B across 66 disclosed positions in Q2 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including TLN, TEVA, FTAI) accounted for 25.6% of total reported equity market value during Q2 2025.
Top New Position Initiated
FLR
市值: $205.1M
Top Position Liquidated / Trimmed
FLG
前期市值: $74.7M
During Q2 2025, Rubric Capital Management LP's top holdings by market value included TLN (19.8%)、TEVA (6.6%)、FTAI (5.9%). The largest single position, TLN, represented 19.8% of total portfolio value.
In Q2 2025, Rubric Capital Management LP made 68 total portfolio adjustments, initiating 10 new buys, adding to 28 positions, trimming 21 holdings, and fully liquidating 9 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.